Opposite rotation induced by dopamine agonists in rats with unilateral lesions of the globus pallidus or substantia nigra

Behavioural Brain Research

Volumn 92, Issue 1, 1998, Pages 77-83

  Konitsiotis, Spyridon ^a   Kafetzopoulos, Evangelos ^a   Anastasopoulos, Dimitrios ^a   Blanchet, Pierre J ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Amphetamine; Apomorphine; Dopamine; Globus pallidus; Rotational behavior; Substantia nigra

Indexed keywords

APOMORPHINE; DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; IBOTENIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN INJURY; CONTROLLED STUDY; GLOBUS PALLIDUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ROTATION; SUBSTANTIA NIGRA;

ANIMALS; APOMORPHINE; DEXTROAMPHETAMINE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; FUNCTIONAL LATERALITY; GLOBUS PALLIDUS; MALE; OXIDOPAMINE; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR; SUBSTANTIA NIGRA;

EID: 0031893998     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)00127-7     Document Type: Article

References (35)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neuroscience. 12:1989;366-376.
2. Anden N.E., Dahlstrom A., Fuxe K., Larsson K. Functional role of the nigrostriatal dopamine neurons. Acta Pharmacol Toxicol. 24:1966;236-274.
3. Asin K.E., Montana W.E. Rotation following intranigral injections of a selective D1 or a selective D2 dopamine receptor agonist in rats. Pharmacol Biochem Behav. 29:1988;89-92.
4. Bergman H., Wichmann T., DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science. 249:1990;1436-1438.
5. Beckstead R.M., Wooten G.F., Trugman J.M. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined bu quantitative autoradiography. J Comp Neurol. 268:1988;131-145.
6. Bergstrom D.A., Bromley S.D., Walters J.R. Apomorphine increases the activity of rat globus pallidus neurons. Brain Research. 238:1982;266-271.
7. 3H]SCH 23390 binding to D1 Dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience. 26:1988;101-119.
8. Blanchet P.J., Boucher R., Bedard P.J. Excitotoxic lateral pallidotomy does not relieve l-dopa-induced dyskinesia in MPTP parkinsonian monkeys. Brain Research. 650:1994;32-39.
9. Bucher S.F., Seelos K.C., Dodel R.C., Paulis W., Reiser M., Oertel W.H. Pallidal lesions:Structural and functional magnetic resonance imaging. Arch Neurol. 53:1996;682-686.
10. Chesselet M-F., Delfs J. Basal ganglia and movement disorders: an update. Trends Neurosci. 19:1996;417-422.
11. Clavier R.M., Atmadja S., Fibiger H.C. Nigrothalamic projections in the rat as demonstrated by orthograde and retrograde tracing techniques. Brain Res Bull. 1:1976;379-384.
12. Feger J. Updating the functional model of the basal ganglia. Trends Neurosci. 20:1997;152-153.
13. Faull R.L.M., Mehler W.R. The cells of origin of nigrotectal, nigrothalamic and nigrostriatal projections in the rat. Neuroscience. 3:1978;989-1002.
14. Graybiel AM, Ragsdale CW. Biochemical anatomy of the striatum. In: Emson PC, editor. Chemical Neuroanatomy. New York: Raven Press, 1983:427-504.
15. Kincaid A.E., Penney J.B., Young A.B., Newman S.W. The globus pallidus receives a projection from the parafascicular nucleus in rat. Brain Research. 553:1991;18-26.
16. Klockgether T., Turski L. Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia. Ann Neurol. 34:1993;585-593.
17. Levy R., Hazrati L.-N., Herrero M.-T., Vila M., Hassani O.-K., Mouroux M., Ruberg M., Asensi H., Agid Y., Feger J., Obeso J.A., Parent A., Hirsch E.C. Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states. Neuroscience. 76:1997;335-343.
18. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Le Bas J.F., Broussolle E., Perret J.E., Benabid A.L. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 345:1995;91-95.
19. Ljungberg T., Ungerstedt U. Automatic registration of behaviour related to dopamine and noradrenaline transmission. Eur J Pharmacol. 36:1976;181-188.
20. Matsumura M., Tremblay L., Richard H., Filion M. Activity of pallidal neurons in the monkey duriong dyskinesia induced by injection of bicuculline in the external pallidum. Neuroscience. 65:1995;59-70.
21. Nauta WJH, Domesick VB. Afferent and efferent relationships of the basal ganglia. In: Evered D, O'Connor M, editors. Functions of the Basal Ganglia (Ciba Foundation Symposium 107). London: Pitman, 1984:3-29.
22. Olds M.E. Amphetamine-induced increase in motor activity is correlated with higher firing rates of non-dopamine neurons in substantia nigra and ventral tegmental area. Neuroscience. 24:1988;477-490.
23. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. II. The place of subthalamic and external pallidum in basal ganglia circuitry. Brain Res Rev. 20:1995;128-154.
24. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd edn. Sydney: Academic Press, 1986.
25. Pycock C.J. Turning behavior in animals. Neuroscience. 5:1980;461-514.
26. Rebec G.V., Groves P.M. Apparent feedback from the caudate nucleus to the substantia nigra following amphetamine administration. Neuropharmacology. 14:1975;275-282.
27. Reid M.S., O'Connor W.T., Herrera-Marshitz M., Ungerstedt U. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors. Brain Research. 519:1990;255-260.
28. Sadicot A.F., Parent A., Francois C. Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: PHA-L study of subcortical projections. J Comp Neurol. 315:1992;137-159.
29. Silvia C.P., King G.R., Lee T.H., Xue Z.Y., Caron M.G., Ellinwood E.H. Intrnigral administration of D-2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D-2 autoreceptors in the motor actions of cocaine. Mol Pharmacol. 46:1994;51-57.
30. Skirboll L.R., Grace A.A., Bunney A.S. Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. Science. 206:1979;80-82.
31. Smith Y., Parent A. Differential connections of caudate nucleus and putamen in the squirrel monkey. Neuroscience. 18:1986;347-371.
32. Smith A.D., Bolam J.P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neuroscience. 13:1990;259-265.
33. Strombom U. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedeberg's Arch Pharmacol. 292:1976;167-176.
34. Vaccheri A., Dall'Olio R., Gandolfi O., Montanaro N. Involvement of different dopamine receptors in rat diphasic motility response to apomorhine. Psychopharmacology. 89:1986;265-268.
35. Waszczak B.L., Lee E.K., Ferraro T., Hare T.H., Walters J.R. Single unit responses of substantia nigra pars reticulata neurons to apomorphine: effects of striatal lesions and anesthesia. Brain Research. 306:1984;307-318.